...
【24h】

Surgical Treatment of Cardiac and Pulmonary Sarcomas

机译:手术治疗的心脏和肺肉瘤

获取原文
获取原文并翻译 | 示例
           

摘要

? 2021 Elsevier Inc.Primary cardiac tumors have an autopsy incidence of between 0.02% and 0.04% or about 200 tumors per 1 million autopsies. Approximately 75% of these neoplasms are benign and 25 % malignant. Primary cardiac sarcomas (PCS) make up over 75% of the primary malignant tumors. The rarity of primary cardiac tumors has led to a minority of surgeons and even few institutions having substantial experience with their treatment. Surgical resection of primary cardiac sarcoma is the mainstay of therapy but is less well understood and far more difficult. Additionally, the preoperative evaluation, preparation and decision making about the ability to achieve complete resection can be complex and has not been standardized. We separate sarcoma into right heart, left heart and pulmonary artery sarcoma as anatomic location often dictates the clinical presentation and the surgical options available. This manuscript presents our approach to the evaluation, preparation and surgical techniques required for treating these primary cardiac sarcomas.
机译:? 解剖的发生率在0.02%和0.04%之间200每100万尸体解剖肿瘤。大约75%的这些肿瘤是良性的和25%的恶性肿瘤。(pc)占超过75%的原发性恶性肿瘤。导致少数的外科医生,甚至一些机构拥有大量的经验他们的治疗。心脏肿瘤治疗的主流,但不太理解的和困难得多。此外,术前评估,准备和决策的能力可以复杂,达到完整切除没有被标准化。到右心,左心和肺动脉肉瘤的解剖位置往往决定了临床表现和手术选项可用。评估,准备和手术治疗这些主要技术要求心脏肉瘤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号